跳至主要内容
临床试验/NCT01426477
NCT01426477终止不适用

Veritas in Non-Bridging Ventral Hernia Repair

Baxter Healthcare Corporation4 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
20
试验地点
4
主要终点
Hernia recurrence

研究概览

简要总结

The main study objective is to determine the frequency of hernia recurrence following use of Veritas Collagen Matrix.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be 18 years of age or older
  • Ability to understand and read English
  • Must be scheduled for open abdominal surgery for repair of primary ventral hernia or first recurrence of a ventral hernia with the Veritas Collagen Matrix using the underlay technique, with our without component separation
  • Must be of ambulatory status
  • Primary closure can be obtained during surgery
  • Repair is such that one piece of Veritas can be used to reinforce the repair

排除标准

  • Hernia is undetectable on physical exam
  • There is evidence of existing cancer
  • Use of chronic immunosuppressive therapy, including steroids or cytotoxic agents
  • Any condition that product labeling indicates would adversely affect participant safety, including sensitivity to bovine products

结局指标

主要结局

Hernia recurrence

时间窗: 2 Years

Recurrence will be evaluated through physical exam and/or CT scans at all study visits (30 days, 6 months, 1 year, and 2 years), or when patients present with symptoms, with primary endpoint at 2 years.

次要结局

  • Number of Medical and Surgical Complications(2 years)
  • Change in Quality of Life(Baseline to 2 Years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验